FDA Foreign Inspections User Fee Program Getting Push On The Hill
Executive Summary
The pharmaceutical industry is facing an increasingly aggressive push to create user fees for manufacturing inspections.
You may also be interested in...
FDA’s Autor Moves To Mylan: Company’s Gain May Also Be Company’s Loss
While Mylan wants Autor to help push quality improvement efforts around the world, her departure from FDA may affect implementation of similar plans at the agency.
U.S. FDA Highlights Hands-On Approach To China Inspections In Budget Plan
The inspection focus of U.S. FDA’s budget request is largely on adding more personnel, but the agency continues to think about how best to target and leverage its resources in its globalization plan.
FDA Highlights Hands-On Approach To China Inspections In Budget Plan
The inspection focus of the budget request is largely on adding more personnel, but the agency continues to think about how best to target and leverage its resources in its globalization plan.